RNA-Seq profiling of circular RNAs in human small cell lung cancer

Epigenomics. 2020 Apr;12(8):685-700. doi: 10.2217/epi-2019-0382. Epub 2020 Feb 21.

Abstract

Aim: We aimed to explore the circular RNA (circRNA) profile of small-cell lung cancer (SCLC). Materials & methods: Total RNA was extracted from six paired SCLC tumors and adjacent noncancerous tissues. Next-generation sequencing was performed to identify the circRNA expression profile of SCLC. Results: We found that five circRNAs were significantly upregulated and 30 circRNAs were significantly downregulated in the SCLC tissues. We confirmed the five upregulated and four randomly selected downregulated circRNAs using real-time quantitative PCR. Notably, circ-STXBP5L was selectively upregulated in SCLC samples, but undetectable in the normal control tissues. Bioinformatics analysis demonstrated that circ-STXBP5L may participate in SCLC carcinogenesis by regulating numerous cancer-related pathways. Conclusion: This study may provide new insights into the early diagnosis and development of targeted therapies for SCLC.

Keywords: RNA-sequencing; biomarker; circ-STXBP5L; circRNAs; expression profile; small-cell lung cancer; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor*
  • Cell Transformation, Neoplastic / genetics
  • Computational Biology / methods
  • Early Detection of Cancer
  • Gene Expression Regulation, Neoplastic*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / therapy
  • RNA, Circular / genetics*
  • RNA-Seq
  • Small Cell Lung Carcinoma / diagnosis
  • Small Cell Lung Carcinoma / genetics*
  • Small Cell Lung Carcinoma / therapy

Substances

  • Biomarkers, Tumor
  • RNA, Circular